Fenfluramine Add-On Therapy of Dravet Syndrome

Abstract

Researchers at Antwerp University Hospital and University of Leuven, Belgium report 12 patients, 7 female and 5 male, age range 3-35 years, with a genetically proven diagnosis of Dravet syndrome who received fenfluramine (mean dose 0.34 (0.12-0.90) mg/kg/day) as add-on therapy.

Keywords

• fenfluramine
• dravet syndrome
• photosensitive epilepsy